15 Best Large-Cap Value Stocks to Buy as the Recession Hits
Goldman Sachs highlighted that equities around the world traded in and out of a bear market — which is often defined as a 20% decline from the recent peak.
Abbvie Inc. (ABBV)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lee Munder Capital Group Lee Munder | 162,787 | $34,107,132 | -3% | 2.26% |
| 2. | Solstein Capital Nadine Terman And Jc Torres | 1,110 | $232,567 | 0.14% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.00 | 1,550 | Officer | 17,644 | 2020-03-20 | Filing | |
| $69.00 | 750 | Officer | 16,844 | 2020-03-20 | Filing | |
| $67.50 | 800 | Officer | 16,094 | 2020-03-20 | Filing | |
| $68.18 | 2,200 | Officer | 15,294 | 2020-03-18 | Filing | |
| $69.00 | 750 | Officer | 16,844 | 2020-03-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $210.54 | 33,132 | 53,234 | 2025-03-31 | Filing | ||
| $209.49 | 25,700 | 86,366 | 2025-03-31 | Filing | ||
| $212.34 | 17,644 | 11,577 | 2025-03-14 | Filing | ||
| $210.53 | 6,168 | 388,929 | 2025-03-03 | Filing | ||
| $205.11 | 92,460 | 395,097 | 2025-02-28 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,010,690 | $630,799,671 | 0.59% | |
| 2. | 1,440,477 | $301,808,741 | 1.15% | |
| 3. | 665,533 | $139,442,474 | 0.23% | |
| 4. | 639,293 | $133,944,656 | 2.6% | |
| 5. | 536,450 | $112,397,875 | 0.21% |
News See All
10 Innovative Healthcare Stocks to Watch in 2025
In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending increased 7.5% from 2022 to $4.9 trillion in 2023.
10 Best Dividend Monarchs to Invest in Now
Dividend-focused investors are generally well-acquainted with terms like Dividend Aristocrats and Dividend Kings, but many may not be aware of a lesser-known group called Dividend Monarchs.
10 Best Pharma Stocks to Buy for Long Term Growth
With big American pharmaceutical corporations always searching for medications in China, the US pharmaceutical industry is going through a unique trend never seen before.
10 High Growth Forever Dividend Stocks To Invest In
Dividend stocks have trailed the broader market over the past two years, largely due to investors favoring AI-focused companies.
Here’s Why Clearbridge Growth Strategy Sold AbbVie (ABBV)
ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Long-Term Stock Portfolio: 15 Best Stocks for 15 Years
Russell Investments believes that 3 features are defining the market outlook for 2025.
15 Best Dividend Aristocrat Stocks with Over 3% Yield
Dividend Aristocrats are the companies that have raised their payouts for 25 consecutive years or more. Dividends have been an important part of the overall market return for a very long time.
13 Best Healthcare Dividend Stocks to Invest in
The US healthcare sector has been at the forefront since the emergence of COVID-19 in 2020, leading to a significant transformation in the industry.
11 Best Pharma Stocks to Buy According to Hedge Funds
The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.
Billionaire Hedge Funds
